logo-loader
AIM:ONC

Oncimmune Holdings PLC

Receive alerts
Market:
AIM
Price
21.00 GBX
Day Change
-
Market Cap:
£15.57 m
52 weeks high
45.00
52 weeks low
13.00

In brief

Oncimmune Holdings PLC is a leading immunodiagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases.

The company has a diversified and growing revenue from its portfolio of diagnostic products to detect early-stage cancer and a contract discovery and development service-based platform, delivering actionable insights into therapies to its pharmaceutical and biotech partners.

Snapshot

  • Oncimmune says build-out of commercial team nearly complete
  • Oncimmune's strategic pivot aims for robust growth in 2024

Insight Widest with the analysis, Proactive gives perspectives that others don't.

Oncimmune is building momentum in key areas says broker finnCap

The City broker's forecasts are unchanged, while it has reiterated its 150p share price target

on 4/6/20